Edition:
India

Auris Medical Holding AG (EARS.OQ)

EARS.OQ on NASDAQ Stock Exchange Capital Market

0.86USD
22 Nov 2017
Change (% chg)

$0.03 (+4.26%)
Prev Close
$0.82
Open
$0.83
Day's High
$0.87
Day's Low
$0.82
Volume
259,072
Avg. Vol
61,131
52-wk High
$1.50
52-wk Low
$0.60

Select another date:

Fri, Oct 13 2017

BRIEF-Auris Medical Holding AG files for resale of up to 7.2 mln common shares

* Auris Medical Holding AG files for resale of up to 7.2 million common shares by selling shareholder, LPC Capital Fund Llc‍​ - SEC Filing Source text: (http://bit.ly/2ggfWjL) Further company coverage:

BRIEF-Auris Medical announces share purchase agreements with Lincoln Park Capital Fund

* Auris Medical announces share purchase agreements with Lincoln Park Capital Fund, Llc

BRIEF-Auris Medical announces transfer to Nasdaq capital market

* Auris Medical Holding AG - co's shares will continue to trade uninterrupted under symbol "EARS."​

BRIEF-Auris Medical provides board of directors update

* Auris Medical Holding Ag - ‍announced resignation of antoine papiernik as a member of board of directors due to disagreement with board​

BRIEF-Auris Medical completes patient recruitment for phase 3 trial of Keyzilen in acute and post-acute tinnitus

* Auris Medical completes patient recruitment for phase 3 TACTT3 trial of Keyzilen in acute and post-acute tinnitus

BRIEF-Auris Medical posts Q2 loss per share CHF 0.12

* Auris Medical provides business update and reports second quarter 2017 financial results

BRIEF-Auris Medical Holding completes acquisition of various assets

* Auris Medical Holding- announced that it has completed its acquisition of various assets related to intranasal betahistine from Otifex Therapeutics

BRIEF-Auris Medical completes enrollment of phase 3 healos trial of am-111 for the treatment of sudden deafness

* Auris Medical completes enrollment of phase 3 healos trial of am-111 for the treatment of sudden deafness

Select another date: